// App-Quantinova.ai

OC 11.5 : Correction of Coagulopathy in Trauma Haemorrhage – Still Room for Improvement. A Secondary Analysis of the ITACTIC trial

Researchers

Presenter

  • C. Lindsay

Principal Investigators

  • N. Curry

  • S. Stanworth

  • R. Davenport

  • K. Brohi

Medical Centers

  • Queen Mary University of London, London, United Kingdom

  • Oslo University Hospital, University of Oslo, Oslo, Norway

  • Amsterdam University Medical Centers, Amsterdam, Noord-Holland, Netherlands

  • University of Oxford, Oxford, United Kingdom

  • Cologne-Merheim Medical Centre, University of Witten/Herdecke, Cologne, Nordrhein-Westfalen, Germany

  • Copenhagen University Hospital, Copenhagen, Denmark

  • Oxford University Hospitals/NHS Blood and Transplant, Oxford, England, United Kingdom

  • Centre for Trauma Science, Queen Mary Univeristy of London, UK - Barts Health NHS Trust, London, UK, London, England, United Kingdom

  • Oslo University Hospital, University of Oslo, Oslo, Norway

Locations

  • United Kingdom

  • Norway

  • Netherlands

  • Germany

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Trauma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A